Show simple item record

dc.contributor.authorConde Martín, María Isabel 
dc.contributor.authorToledo Lobo, María del Val 
dc.contributor.authorZamora Romero, Javier
dc.contributor.authorPérez Márquez, Julio 
dc.contributor.authorGonzalez, Francisco J.
dc.contributor.authorAlba Conejo, Emilio
dc.contributor.authorFraile Laiz, Benito 
dc.contributor.authorPaniagua Gómez-Álvarez, Ricardo 
dc.contributor.authorArenas Jiménez, María Isabel 
dc.date.accessioned2010-02-12T13:09:53Z
dc.date.available2010-02-12T13:09:53Z
dc.date.issued2008
dc.identifier.bibliographicCitationBMC Cancer 2008, 8:174en
dc.identifier.issn1471-2407
dc.identifier.urihttp://hdl.handle.net/10017/5604
dc.description.abstractThe human pregnane X receptor (hPXR) is an orphan nuclear receptor that induces transcription of response elements present in steroid-inducible cytochrome P 450 gene promoters. This activation requires the participation of retinoid X receptors (RXRs), needed partners of hPXR to form heterodimers. We have investigated the expression of hPXR and RXRs in normal, premalignant, and malignant breast tissues, in order to det. whether their expression profile in localized infiltrative breast cancer is assocd. with an increased risk of recurrent disease. Methods: Breast samples from 99 patients including benign breast diseases, in situ and infiltrative carcinomas were processed for immunohistochem. and Western-blot anal. Results: Cancer cells from patients that developed recurrent disease showed a high cytoplasmic location of both hPXR isoforms. Only the infiltrative carcinomas that relapsed before 48 mo showed nuclear location of hPXR isoform 2. This location was assocd. with the nuclear immunoexpression of RXR-alpha. Conclusion: Breast cancer cells can express both variants 1 and 2 of hPXR. Infiltrative carcinomas that recurred showed a nuclear location of both hPXR and RXR-alpha; therefore, the overexpression and the subcellular location changes of hPXR could be considered as a potential new prognostic indicator.en
dc.format.mimetypeapplication/pdfen
dc.language.isoengen
dc.publisherBioMed Centralen
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Españaes_ES
dc.rights© Conde et al; licensee BioMed Central Ltd., 2008en
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.subjectHuman pregnane X receptoren
dc.subjectBreast canceren
dc.titleHuman pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alpha.en
dc.typeinfo:eu-repo/semantics/articleen
dc.subject.ecienciaBiologíaes_ES
dc.subject.ecienciaBiologyen
dc.subject.ecienciaGenéticaes_ES
dc.subject.ecienciaGeneticsen
dc.subject.ecienciaCienciaes_ES
dc.subject.ecienciaScienceen
dc.contributor.affiliationUniversidad de Alcalá. Departamento de Biología Celular y Genética
dc.relation.publisherversionhttp://dx.doi.org/10.1186/1471-2407-8-174
dc.type.versioninfo:eu-repo/semantics/publishedVersionen
dc.identifier.doi10.1186/1471-2407-8-174
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Atribución-NoComercial-SinDerivadas 3.0 España
Este ítem está sujeto a una licencia Creative Commons.